Remove 2024 Remove Degenerative Disc Disease Remove Treatment
article thumbnail

Degenerative Disc Disease Treatment Market Is Expected To Reach Revenue Of USD 66.2 Bn By 2033, At 7.7% CAGR: Dimension Market Research

OrthoSpineNews

Advancements and Projections in the Global Degenerative Disc Disease Treatment Market: Insights, Trends, Opportunities, and Recent Developments New York, Oct. 08, 2024 (GLOBE NEWSWIRE) — Overview – The Global Degenerative Disc Disease Treatment Market is projected to reach USD 34.0

article thumbnail

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD). Accessed August 2024.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

33 Medical Wins 2024 Best Technology in Spine Award for Innovative NuvoDisc® Device

OrthoSpineNews

27, 2024 (GLOBE NEWSWIRE) — 33 Medical, Inc., a leader in cutting-edge spinal health innovations, is proud to announce that its NuvoDisc® medical device has been awarded the prestigious 2024 Best Technology in Spine Award. Boca Raton, FL, Sept.

article thumbnail

Landmark Clinical Study Demonstrates Superiority of 3-Level Circumferential Cervical Fusion Over Anterior Cervical Fusion Alone

OrthoSpineNews

July 11, 2024 /PRNewswire/ — Providence Medical Technology announces FDA Clearance of its CORUS™ Posterior Cervical Stabilization System (PCSS) for the treatment of up to 3-level cervical Degenerative Disc Disease (DDD).

article thumbnail

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

OrthoSpineNews

Furthermore, 52 week comparison of MRI images to baseline appear to demonstrate morphological changes, such as increase in T2 signal (hydration), decrease in protrusion size, as well as resolutions of annular tears, potentially demonstrating disc microenvironment remodeling as a result of cLDD treatment with BRTX-100.

article thumbnail

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

OrthoSpineNews

Explore trends, segmentation, and growth drivers- View Free Sample PDF Spinal Implants Market Scope Report Coverage Details Base year 2024 Historic period 2019 – 2023 Forecast period 2025-2029 Growth momentum & CAGR Accelerate at a CAGR of 5.3% Key insights into market evolution with AI-powered analysis. JAYON IMPLANTS Pvt.